Basic Information
RNALocate ID: | RLID:11002413 |
RNA Symbol: | hsa-miR-30e-3p |
Localization: | Microvesicle |
RNA Information
RNA Name: | hsa-miR-30e-3p |
RNA ID: | miRBase:MIMAT0000693 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 24797360 |
Tissue/Cell Line: | Serum |
Method: | RNA sequencing |
Description: | Differentially expressed miRNAs detected in the serum (SER). Data are collected from Table 2. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002007 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01002008 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:11002406 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11002407 | Exosome | Breast milk | 22211110 |
RLID:11002408 | Exosome | Brain tissue | 23382797 |
RLID:11002409 | Exosome | Plasma | 23663360 |
RLID:11002410 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11002411 | Microvesicle | Seminal plasma | 23539611 |
RLID:11002412 | Microvesicle | Follicular fluid | 23666971 |
RLID-D:11000116 | Exosome | B lymphoblastoid cells|Chronic lymphocytic leukemia cells|Endothelial cells|Lymphoma tissue|Mast cells | |
RLID-D:11000405 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-30e-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-37636 |
MNDR | hsa-miR-30e-3p | Oral squamous cell carcinoma | MNDR-E-MI-37637 |
MNDR | hsa-miR-30e-3p | Large cell neuroendocrine cancer | MNDR-E-MI-37638 |
MNDR | hsa-miR-30e-3p | Lymphoma | MNDR-E-MI-37639 |
MNDR | hsa-miR-30e-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-37640 |
MNDR | hsa-miR-30e-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-37641 |
MNDR | hsa-miR-30e-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-37642 |
MNDR | hsa-miR-30e-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-37643 |
MNDR | hsa-miR-30e-3p | Her2-receptor positive breast cancer | MNDR-E-MI-37644 |
MNDR | hsa-miR-30e-3p | Niemann-pick disease type c | MNDR-E-MI-37645 |
MNDR | hsa-miR-30e-3p | Dermatomyositis | MNDR-E-MI-37646 |
MNDR | hsa-miR-30e-3p | Prostate cancer | MNDR-E-MI-37647 |
MNDR | hsa-miR-30e-3p | Gastric cancer | MNDR-E-MI-37648 |
MNDR | hsa-miR-30e-3p | Gastric lymphoma | MNDR-E-MI-37649 |
MNDR | hsa-miR-30e-3p | Alzheimer disease | MNDR-E-MI-37650 |
MNDR | hsa-miR-30e-3p | Intracranial aneurysm | MNDR-E-MI-37651 |
MNDR | hsa-miR-30e-3p | Esophageal carcinoma | MNDR-E-MI-37652 |
MNDR | hsa-miR-30e-3p | Head and neck cancer | MNDR-E-MI-37653 |
MNDR | hsa-miR-30e-3p | Cardiovascular disease | MNDR-E-MI-37654 |
MNDR | hsa-miR-30e-3p | Lung cancer | MNDR-E-MI-37655 |
MNDR | hsa-miR-30e-3p | Parkinson disease | MNDR-E-MI-37656 |
MNDR | hsa-miR-30e-3p | Niemann-pick disease | MNDR-E-MI-37657 |
MNDR | hsa-miR-30e-3p | Basal-like breast cancer | MNDR-E-MI-37658 |
MNDR | hsa-miR-30e-3p | Thyroid cancer | MNDR-E-MI-37659 |
MNDR | hsa-miR-30e-3p | Pancreatic cancer | MNDR-E-MI-37660 |
MNDR | hsa-miR-30e-3p | Melanoma | MNDR-E-MI-37661 |
MNDR | hsa-miR-30e-3p | Rectum adenocarcinoma | MNDR-E-MI-37662 |
MNDR | hsa-miR-30e-3p | Nephroblastoma | MNDR-E-MI-37663 |
MNDR | hsa-miR-30e-3p | Colon cancer | MNDR-E-MI-37664 |
MNDR | hsa-miR-30e-3p | Ischemic attack transient | MNDR-E-MI-37665 |
MNDR | hsa-miR-30e-3p | Colon adenocarcinoma | MNDR-E-MI-37666 |
MNDR | hsa-miR-30e-3p | West nile virus infection | MNDR-E-MI-37667 |
MNDR | hsa-miR-30e-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-37668 |
MNDR | hsa-miR-30e-3p | Familial ovarian cancer | MNDR-E-MI-37669 |
MNDR | hsa-miR-30e-3p | Prostate adenocarcinoma | MNDR-E-MI-37670 |
MNDR | hsa-miR-30e-3p | Carcinoma ductal breast | MNDR-E-MI-37671 |
MNDR | hsa-miR-30e-3p | Glioblastoma | MNDR-E-MI-37672 |
MNDR | hsa-miR-30e-3p | Glioma | MNDR-E-MI-37673 |
MNDR | hsa-miR-30e-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-37674 |
MNDR | hsa-miR-30e-3p | Osteosarcoma | MNDR-E-MI-37675 |
MNDR | hsa-miR-30e-3p | Inclusion body myositis | MNDR-E-MI-37676 |
MNDR | hsa-miR-30e-3p | Meningioma | MNDR-E-MI-37677 |
MNDR | hsa-miR-30e-3p | Gastric adenocarcinoma | MNDR-E-MI-37678 |
MNDR | hsa-miR-30e-3p | Cervical squamous cell carcinoma | MNDR-E-MI-37679 |
MNDR | hsa-miR-30e-3p | Bone-invasive pituitary adenoma | MNDR-E-MI-37680 |
MNDR | hsa-miR-30e-3p | Lung squamous cell carcinoma | MNDR-E-MI-37681 |
MNDR | hsa-miR-30e-3p | Lung adenocarcinoma | MNDR-E-MI-37682 |
MNDR | hsa-miR-30e-3p | Thyroid carcinoma | MNDR-E-MI-37683 |
MNDR | hsa-miR-30e-3p | Bladder urothelial carcinoma | MNDR-E-MI-37684 |
MNDR | hsa-miR-30e-3p | Carcinoma renal cell | MNDR-E-MI-37685 |
MNDR | hsa-miR-30e-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-37686 |
MNDR | hsa-miR-30e-3p | Clear cell renal cell carcinoma | MNDR-E-MI-37687 |
MNDR | hsa-miR-30e-3p | Large cell carcinoma | MNDR-E-MI-37688 |
MNDR | hsa-miR-30e-3p | Cholangiocarcinoma | MNDR-E-MI-37689 |
MNDR | hsa-miR-30e-3p | Esophageal cancer | MNDR-E-MI-37690 |
MNDR | hsa-miR-30e-3p | Lung small cell carcinoma | MNDR-E-MI-37691 |
MNDR | hsa-miR-30e-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-37692 |
MNDR | hsa-miR-30e-3p | Testicular germ cell cancer | MNDR-E-MI-37693 |
MNDR | hsa-miR-30e-3p | Breast invasive carcinoma | MNDR-E-MI-37694 |
MNDR | hsa-miR-30e-3p | Hepatocellular carcinoma | MNDR-E-MI-37695 |
MNDR | hsa-miR-30e-3p | Familiar ovarian carcinoma | MNDR-E-MI-37696 |
MNDR | hsa-miR-30e-3p | Rheumatoid arthritis | MNDR-E-MI-37697 |
MNDR | hsa-miR-30e-3p | Malignant pleural mesothelioma | MNDR-E-MI-37698 |
MNDR | hsa-miR-30e-3p | Barrett's adenocarcinoma | MNDR-E-MI-37699 |
MNDR | hsa-miR-30e-3p | Hodgkin lymphoma | MNDR-E-MI-37700 |
MNDR | hsa-miR-30e-3p | Tonsil cancer | MNDR-E-MI-37701 |
MNDR | hsa-miR-30e-3p | Neuromyelitis optica | MNDR-E-MI-37702 |
MNDR | hsa-miR-30e-3p | Colorectal cancer | MNDR-E-MI-37703 |
MNDR | hsa-miR-30e-3p | Nasopharynx carcinoma | MNDR-E-MI-37704 |
MNDR | hsa-miR-30e-3p | Cardiomegaly | MNDR-E-MI-37705 |
MNDR | hsa-miR-30e-3p | Nasopharyngeal cancer | MNDR-E-MI-37706 |
MNDR | hsa-miR-30e-3p | Wounds and injuries | MNDR-E-MI-37707 |
MNDR | hsa-miR-30e-3p | Cerebral hemorrhage traumatic | MNDR-E-MI-37708 |
MNDR | hsa-miR-30e-3p | Intracranial hemorrhage hypertensive | MNDR-E-MI-37709 |
MNDR | hsa-miR-30e-3p | Peripheral nerve injuries | MNDR-E-MI-37710 |
MNDR | hsa-miR-30e-3p | Chronic pain | MNDR-E-MI-37711 |
MNDR | hsa-miR-30e-3p | Stroke lacunar | MNDR-E-MI-37712 |
MNDR | hsa-miR-30e-3p | Barrett's carcinogenesis | MNDR-E-MI-37713 |
MNDR | hsa-miR-30e-3p | Breast cancer her3+ negative | MNDR-E-MI-37714 |
MNDR | hsa-miR-30e-3p | Duke C | MNDR-E-MI-37715 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ATF3 | Homo sapiens | RR00155509 |
TOP